$358.92
0.26% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US8636671013
Symbol
SYK

Stryker Stock price

$358.92
+36.25 11.23% 1M
+3.92 1.10% 6M
+59.46 19.86% YTD
+69.82 24.15% 1Y
+82.27 29.74% 3Y
+137.52 62.11% 5Y
+274.65 325.92% 10Y
NYSE, Closing price Fri, Sep 06 2024
+0.92 0.26%
ISIN
US8636671013
Symbol
SYK
Sector

Key metrics

Market capitalization $136.78b
Enterprise Value $147.56b
P/E (TTM) P/E ratio 40.03
EV/FCF (TTM) EV/FCF 52.64
EV/Sales (TTM) EV/Sales 6.90
P/S ratio (TTM) P/S ratio 6.39
P/B ratio (TTM) P/B ratio 6.92
Dividend yield 0.85%
Last dividend (FY23) $3.05
Revenue growth (TTM) Revenue growth 9.94%
Revenue (TTM) Revenue $21.39b
EBIT (operating result TTM) EBIT $4.57b
Free Cash Flow (TTM) Free Cash Flow $2.80b
Cash position $1.96b
EPS (TTM) EPS $8.97
P/E forward 35.25
P/S forward 6.11
EV/Sales forward 6.59
Short interest 1.04%
Show more

Is Stryker a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Stryker Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Stryker forecast:

22x Buy
69%
9x Hold
28%
1x Sell
3%

Analyst Opinions

32 Analysts have issued a Stryker forecast:

Buy
69%
Hold
28%
Sell
3%

Financial data from Stryker

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
21,389 21,389
10% 10%
100%
- Direct Costs 8,297 8,297
6% 6%
39%
13,092 13,092
13% 13%
61%
- Selling and Administrative Expenses 6,119 6,119
13% 13%
29%
- Research and Development Expense 1,371 1,371
11% 11%
6%
5,602 5,602
12% 12%
26%
- Depreciation and Amortization 1,030 1,030
1% 1%
5%
EBIT (Operating Income) EBIT 4,572 4,572
15% 15%
21%
Net Profit 3,448 3,448
27% 27%
16%

In millions USD.

Don't miss a Thing! We will send you all news about Stryker directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Stryker Stock News

Neutral
Seeking Alpha
one day ago
Stryker Corporation (NYSE:SYK ) Wells Fargo 2024 Healthcare Conference Call September 5, 2024 3:00 PM ET Company Participants Spencer Stiles - Group President, Orthopedics and Spine Jason Beach - Vice President, Investor Relations Conference Call Participants Larry Biegelsen - Wells Fargo All right, welcome back. I'm Larry Biegelsen, the medical device analyst at Wells Fargo.
Neutral
GlobeNewsWire
16 days ago
Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis.
Neutral
GlobeNewsWire
19 days ago
Portage, Michigan, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, at the Encore Boston Harbor.
More Stryker News

Company Profile

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Head office United States
CEO Kevin Lobo
Employees 52,000
Founded 1941
Website www.stryker.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today